US Stock MarketDetailed Quotes

BGLC BioNexus Gene Lab

Watchlist

0.430
-0.004-0.88%

Close Oct 3 16:00 ET

0.440
+0.010+2.35%

Post 16:02 ET

7.73MMarket Cap-3049P/E (TTM)

BioNexus Gene Lab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2,714.67%-670.54K

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

-2.21%308.89K

Net income from continuing operations

176.80%199.1K

-50.23%-103.76K

-638.57%-2.63M

296.51%308.46K

-3,271.00%-2.61M

-86.97%-259.25K

-504.70%-69.07K

-147.36%-355.97K

-275.89%-156.97K

-126.21%-77.4K

Operating gains losses

-80.29%-20K

-73.95%-15.13K

46.78%-61.41K

84.86%-12.52K

-117.15%-29.1K

8.27%-11.09K

-20.28%-8.7K

-423.59%-115.38K

-865.70%-82.65K

-454.76%-13.4K

Depreciation and amortization

27.83%31.46K

18.97%29.59K

2.85%108.42K

13.81%29.66K

13.38%29.29K

-8.45%24.61K

-6.68%24.87K

-2.58%105.42K

-1.73%26.06K

-3.67%25.83K

Other non cash items

1,148.99%30.39K

52.39%2.71K

13.90%8.88K

-8.36%2.08K

48.73%2.58K

--2.43K

--1.78K

--7.79K

--2.27K

--1.74K

Change In working capital

-1,312.91%-326.33K

113.98%3.92K

-85.84%117.98K

-98.32%12.44K

-65.22%106.64K

119.88%26.91K

64.14%-28.01K

196.65%833.39K

104.40%740.15K

5,969.93%306.65K

-Change in receivables

1,192.19%153.23K

-131.16%-105.67K

9.71%606.16K

7.83%72.59K

871.71%208.55K

-108.70%-14.03K

12.12%339.05K

-14.24%552.51K

-91.07%67.32K

108.15%21.46K

-Change in inventory

116.51%43.95K

-22.20%60.82K

-129.48%-160.39K

-125.30%-29.89K

-86.20%57.46K

-294.68%-266.14K

161.56%78.17K

257.37%544.11K

445.06%118.14K

93.20%416.26K

-Change in payables and accrued expense

-259.54%-513.65K

112.75%55.23K

-218.55%-381.29K

-102.57%-16.68K

-89.55%-253.51K

175.39%321.95K

-107.57%-433.06K

89.86%-119.7K

265.29%649.74K

-381.72%-133.74K

-Change in other current liabilities

-53.69%-10.23K

-175.79%-12.04K

160.48%76.62K

95.10%-5.37K

1,696.16%93.01K

-7.74%-6.65K

12.80%-4.37K

-528.12%-126.69K

-2,431.20%-109.68K

-18.56%-5.83K

-Change in other working capital

104.36%359

171.50%5.58K

-37.20%-23.12K

-156.19%-8.22K

-86.77%1.12K

-7,589.72%-8.23K

80.43%-7.8K

-142.16%-16.85K

--14.63K

--8.5K

Cash from discontinued investing activities

Operating cash flow

-2,714.67%-670.54K

70.44%-34.44K

-335.87%-1.3M

-154.94%-261.91K

-391.15%-899.35K

87.84%-23.82K

-207.93%-116.52K

5,923.60%551.82K

-1.30%476.74K

-2.21%308.89K

Investing cash flow

Cash flow from continuing investing activities

2,816.22%83.06K

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

131.34%18.36K

Net PPE purchase and sale

87.23%-1.83K

-21,414.71%-21.95K

-175.79%-149.4K

94.50%-937

-3,561.28%-134K

-1,010.29%-14.36K

99.68%-102

-1,613.19%-54.17K

-1,231.27%-17.03K

-792.68%-3.66K

Net investment purchase and sale

-2,172.77%-4.19K

371.85%37.1K

42.43%-294.59K

77.73%-25.33K

-3,851.44%-255.81K

100.09%202

92.07%-13.65K

-0.44%-511.71K

-36.09%-113.73K

111.26%6.82K

Cash from discontinued investing activities

Investing cash flow

2,816.22%83.06K

576.62%24.1K

15.08%-382.58K

72.44%-13.75K

-2,064.65%-360.71K

98.62%-3.06K

97.44%-5.06K

8.17%-450.5K

34.59%-49.9K

131.34%18.36K

Financing cash flow

Cash flow from continuing financing activities

7,234.40%173.58K

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

-2.43K

-1.78K

483.28%108.17K

54.16%-2.27K

71.45%-1.74K

Net issuance payments of debt

----

--0

----

-29.41%-34.04K

--0

Net common stock issuance

----

--0

Cash dividends paid

--0

Net other financing activities

--175.41K

--26.93K

3,742.13%5.76M

----

7,912.50%150K

----

Cash from discontinued financing activities

Financing cash flow

7,234.40%173.58K

1,461.38%24.22K

5,219.80%5.75M

589.05%11.12K

331,172.47%5.75M

---2.43K

---1.78K

483.28%108.17K

54.16%-2.27K

71.45%-1.74K

Net cash flow

Beginning cash position

195.57%5.83M

179.84%5.93M

-0.24%2.12M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

-23.81%2.12M

-14.00%1.46M

-9.60%1.34M

Current changes in cash

-1,311.95%-413.9K

111.25%13.88K

1,842.87%4.07M

-162.31%-264.55K

1,278.54%4.49M

90.41%-29.31K

47.50%-123.35K

141.11%209.49K

5.68%424.56K

29.58%325.52K

Effect of exchange rate changes

97.71%-4.25K

-397.91%-111.03K

-21.04%-259.68K

-79.75%47K

51.29%-99.16K

6.63%-185.22K

50.03%-22.3K

-39.19%-214.55K

966.13%232.03K

-507.38%-203.58K

End cash Position

207.85%5.41M

195.57%5.83M

179.84%5.93M

320.37%6.15M

31.21%1.76M

6.99%1.97M

-0.24%2.12M

-14.00%1.46M

Free cash flow

-1,661.11%-672.37K

51.65%-56.39K

-391.57%-1.45M

-157.18%-262.85K

-438.55%-1.03M

80.65%-38.18K

-66.53%-116.62K

8,195.57%497.65K

-4.57%459.71K

-3.24%305.23K

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2,714.67%-670.54K	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K	-2.21%308.89K
Net income from continuing operations	176.80%199.1K	-50.23%-103.76K	-638.57%-2.63M	296.51%308.46K	-3,271.00%-2.61M	-86.97%-259.25K	-504.70%-69.07K	-147.36%-355.97K	-275.89%-156.97K	-126.21%-77.4K
Operating gains losses	-80.29%-20K	-73.95%-15.13K	46.78%-61.41K	84.86%-12.52K	-117.15%-29.1K	8.27%-11.09K	-20.28%-8.7K	-423.59%-115.38K	-865.70%-82.65K	-454.76%-13.4K
Depreciation and amortization	27.83%31.46K	18.97%29.59K	2.85%108.42K	13.81%29.66K	13.38%29.29K	-8.45%24.61K	-6.68%24.87K	-2.58%105.42K	-1.73%26.06K	-3.67%25.83K
Other non cash items	1,148.99%30.39K	52.39%2.71K	13.90%8.88K	-8.36%2.08K	48.73%2.58K	--2.43K	--1.78K	--7.79K	--2.27K	--1.74K
Change In working capital	-1,312.91%-326.33K	113.98%3.92K	-85.84%117.98K	-98.32%12.44K	-65.22%106.64K	119.88%26.91K	64.14%-28.01K	196.65%833.39K	104.40%740.15K	5,969.93%306.65K
-Change in receivables	1,192.19%153.23K	-131.16%-105.67K	9.71%606.16K	7.83%72.59K	871.71%208.55K	-108.70%-14.03K	12.12%339.05K	-14.24%552.51K	-91.07%67.32K	108.15%21.46K
-Change in inventory	116.51%43.95K	-22.20%60.82K	-129.48%-160.39K	-125.30%-29.89K	-86.20%57.46K	-294.68%-266.14K	161.56%78.17K	257.37%544.11K	445.06%118.14K	93.20%416.26K
-Change in payables and accrued expense	-259.54%-513.65K	112.75%55.23K	-218.55%-381.29K	-102.57%-16.68K	-89.55%-253.51K	175.39%321.95K	-107.57%-433.06K	89.86%-119.7K	265.29%649.74K	-381.72%-133.74K
-Change in other current liabilities	-53.69%-10.23K	-175.79%-12.04K	160.48%76.62K	95.10%-5.37K	1,696.16%93.01K	-7.74%-6.65K	12.80%-4.37K	-528.12%-126.69K	-2,431.20%-109.68K	-18.56%-5.83K
-Change in other working capital	104.36%359	171.50%5.58K	-37.20%-23.12K	-156.19%-8.22K	-86.77%1.12K	-7,589.72%-8.23K	80.43%-7.8K	-142.16%-16.85K	--14.63K	--8.5K
Cash from discontinued investing activities
Operating cash flow	-2,714.67%-670.54K	70.44%-34.44K	-335.87%-1.3M	-154.94%-261.91K	-391.15%-899.35K	87.84%-23.82K	-207.93%-116.52K	5,923.60%551.82K	-1.30%476.74K	-2.21%308.89K
Investing cash flow
Cash flow from continuing investing activities	2,816.22%83.06K	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K	131.34%18.36K
Net PPE purchase and sale	87.23%-1.83K	-21,414.71%-21.95K	-175.79%-149.4K	94.50%-937	-3,561.28%-134K	-1,010.29%-14.36K	99.68%-102	-1,613.19%-54.17K	-1,231.27%-17.03K	-792.68%-3.66K
Net investment purchase and sale	-2,172.77%-4.19K	371.85%37.1K	42.43%-294.59K	77.73%-25.33K	-3,851.44%-255.81K	100.09%202	92.07%-13.65K	-0.44%-511.71K	-36.09%-113.73K	111.26%6.82K
Cash from discontinued investing activities
Investing cash flow	2,816.22%83.06K	576.62%24.1K	15.08%-382.58K	72.44%-13.75K	-2,064.65%-360.71K	98.62%-3.06K	97.44%-5.06K	8.17%-450.5K	34.59%-49.9K	131.34%18.36K
Financing cash flow
Cash flow from continuing financing activities	7,234.40%173.58K	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	-2.43K	-1.78K	483.28%108.17K	54.16%-2.27K	71.45%-1.74K
Net issuance payments of debt	----	----	--0	--0	----	----	----	-29.41%-34.04K	--0	--0
Net common stock issuance	----	----	----	----	----	----	----	----	----	--0
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Net other financing activities	--175.41K	--26.93K	3,742.13%5.76M	----	----	----	----	7,912.50%150K	----	----
Cash from discontinued financing activities
Financing cash flow	7,234.40%173.58K	1,461.38%24.22K	5,219.80%5.75M	589.05%11.12K	331,172.47%5.75M	---2.43K	---1.78K	483.28%108.17K	54.16%-2.27K	71.45%-1.74K
Net cash flow
Beginning cash position	195.57%5.83M	179.84%5.93M	-0.24%2.12M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-23.81%2.12M	-14.00%1.46M	-9.60%1.34M
Current changes in cash	-1,311.95%-413.9K	111.25%13.88K	1,842.87%4.07M	-162.31%-264.55K	1,278.54%4.49M	90.41%-29.31K	47.50%-123.35K	141.11%209.49K	5.68%424.56K	29.58%325.52K
Effect of exchange rate changes	97.71%-4.25K	-397.91%-111.03K	-21.04%-259.68K	-79.75%47K	51.29%-99.16K	6.63%-185.22K	50.03%-22.3K	-39.19%-214.55K	966.13%232.03K	-507.38%-203.58K
End cash Position	207.85%5.41M	195.57%5.83M	179.84%5.93M	179.84%5.93M	320.37%6.15M	31.21%1.76M	6.99%1.97M	-0.24%2.12M	-0.24%2.12M	-14.00%1.46M
Free cash flow	-1,661.11%-672.37K	51.65%-56.39K	-391.57%-1.45M	-157.18%-262.85K	-438.55%-1.03M	80.65%-38.18K	-66.53%-116.62K	8,195.57%497.65K	-4.57%459.71K	-3.24%305.23K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data